U.S. FDA announces 4 new veterinary innovation centres

The U.S. Food and Drug Administration’s Center for Veterinary Medicine announced last week the establishment of four animal and veterinary innovation centres that have received funding for work to advance regulatory science and develop innovative products and approaches to better support animal health and veterinary interventions. These centres are expected to further the goals outlined in the FDA’s Animal and Veterinary Innovation Agenda, which describes the agency’s plan to spur innovation to better protect human...

U.S. FDA clears new Zenrelia tablets to treat itchy dogs

The U.S. Food and Drug Administration last week approved Zenrelia, or ilunocitinib tablets, a new veterinary drug from Elanco Animal Health, Inc., based in Greenfield, Indiana, to control pruritus, or itching, associated with allergic dermatitis and to control atopic dermatitis, or environmental allergies, in dogs that are at least a year old. According to Elanco Animal Health, itching is one of the top reasons pet owners take their dogs to the veterinarian, and pet owners...